Search results
MD, PhD. Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Director, Harvard/MIT MD-PhD Program. Professor of Pediatrics, Harvard Medical School. Request an Appointment. Phone: 888-733-4662.
Dr. Walensky is currently Principal Investigator and Attending Physician in the Department of Pediatric Oncology at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Professor Pediatrics at Harvard Medical School; and Director of the Harvard/MIT MD-PhD Program.
People also ask
Who is Dr Walensky?
Who is Loren David Walensky?
Where did Dr Walensky go to medical school?
Loren David Walensky is an American physician-scientist and pediatric oncologist at the Dana–Farber Cancer Institute since 2003 and a professor of pediatrics at the Dana–Farber/Harvard Cancer Center.
- 3
- .mw-parser-output .marriage-line-margin2px{line-height:0;margin-bottom:-2px}.mw-parser-output .marriage-line-margin3px{line-height:0;margin-bottom:-3px}.mw-parser-output .marriage-display-ws{display:inline;white-space:nowrap}, Rochelle Walensky (m. 1995)
Dr. Walensky is currently Principal Investigator and Attending Physician in the Department of Pediatric Oncology at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Professor Pediatrics at Harvard Medical School; and Director of the Harvard/MIT MD-PhD Program.
486. 2010. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. GL Verdine, LD Walensky. Clinical cancer research 13 (24), 7264-7270. , 2007. 475. 2007. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
25 Shattuck Street Boston, MA 02115 CSS Styles Code. fcf2c6b74fbdd7d4cf432a1c39a278f0
Aug 23, 2012 · Loren D Walensky is an Associate Professor of Pediatrics at Harvard Medical School, faculty member in the Department of Pediatric Hematology/Oncology at Dana-Farber Cancer Institute/Children’s Hospital Boston, and Medical Director of Dana-Farber’s Program in Cancer Chemical Biology.
